• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    |
    Weekly News Recap #Phispers
    Sarepta inks US$ 11 bn RNA deal with Arrowhead; Roche expands CAR-T arsenal; Novartis buys Kate for US$ 1 bn

    Sarepta inks US$ 11 bn RNA deal with Arrowhead; Roche expands CAR-T arsenal; Novartis buys Kate for US$ 1 bn

    The week saw three large deals signed in promising fields. First, Sarepta Therapeutics signed a US$ 11.4 billion deal with Ar...

    Impressions : 1936

    Lilly to acquire IBD drug developer Morphic for US$ 3.2 bn; Pfizer’s R&D chief to step down

    Lilly to acquire IBD drug developer Morphic for US$ 3.2 bn; Pfizer’s R&D chief to step down

    This week saw Eli Lilly strike yet another deal as it announced the acquisition of Morphic Holding for about US$ 3.2 billion, t...

    Impressions : 1364

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.